Cannabiz Issue 1

More documents

Recommendations

Info

123, St. George’s Road, St. Julian’s, Malta 2000 sq.m of New, Highly Finished Office Space ...in the Heart of St. Julian’s Offices finished to the highest standards and equipped with all necessary services and systems creating a modern, cutting-edge office space environment. Located in the central part of St. Julian’s/Paceville area, this office block sits right opposite Mercury Tower, overlooking planned piazza. This property is located just 2 minutes away from bus stops, 5 minutes away from closest taxi stand and within walking distance from prime renting localities such as Swieqi, Pembroke, Ibragg and Sliema. These offices are within Malta’s prime entertaining/nightlife hub. Project Completion: 2020
WHAT TO EXPECT MEDICAL CANNABIZ WORLD CONFERENCE 3, 5 TH NOV - Social Impact and Education When it comes to medical cannabis, education and public awareness have been a driving force in bringing new legislation to the fore. Hannah Deacon, a speaker at the Medical <strong>Cannabiz</strong> World in November, has been a key figure in Britain’s changing laws on medical cannabis after spearheading a motion to introduce medical cannabis licences to UK law. Following the decline of her son’s health due to severe seizures, Hannah was instrumental in campaigning for a fresh perspective to the way the health care system in Britain sees medical cannabis as a treatment option. In 2018 she eventually secured a change in law and worked closely with the Home Office to fine tune the prescription application process. Prior to the change, medical cannabis was classed as a schedule one drug under the Misuse of Drugs Regulations 2001, which meant it was not recognised to have any therapeutic value. Nonetheless, medical cannabis is still not widely available in the UK. Patients must meet very specific criteria in order to be eligible for a prescription and costs associated with the process remain high. As she and others will tell you, one of the biggest challenges has been to combat negative public opinion. Stigma around the drug, including from those in the medical industry has made it an uphill struggle for those seeking acceptance and support. In fact many still view it through long-held stereotypes, labelling it a dangerous gateway drug. Tracy Ryan, who is also scheduled to speak at the summit, recalls her fear that despite acting within the boundaries of the law, she would still face censure. An additional struggle has been bringing the medical profession on board. A lack of training and clarity from the law means many are hesitant to involve themselves, even if the law allows them to do so. UK guidelines published in October 2019 by the National Institute for Health and Care Excellence will help mitigate some of the apprehension felt by doctors, by providing them with the information they need to feel confident in prescribing medical cannabis. How the industry navigates these hurdles along with non-governmental associations and patient advocacy groups will be crucial if the healthcare industry is to adequately service the needs of patients suffering from chronic and painful illnesses. The third Medical <strong>Cannabiz</strong> World conference on Social Impact and Education will take place on the 5th of November. HANNAH DEACON Campaigner for medical cannabis MIKE BARNES Chair, The Medical Cannabis Clinicians Society MAYA ELISABETH CEO, Whoopi & Maya CANNABIZ .1 23
Page 1: ISSUE 1 - FALL / WINTER 2019 THE FU
Page 4 and 5: EDITOR - Katy Micallef PHOTOGRAPHER
Page 6 and 7: CONTENTS 10 11 16 28 34 38 Medical
Page 8: The free blockchain traceability pl
Page 11 and 12: INTRODUCTION Malta: Island of Innov
Page 13 and 14: INTRODUCTION GETTING THE GREEN LIGH
Page 15 and 16: FEATURE OLIVER DE BONO, COO FOR SIG
Page 17 and 18: FEATURE A robust regulatory infrast
Page 19 and 20: WHAT THE VIPS HAD TO SAY BEN GOERTZ
Page 21: WHAT TO EXPECT MEDICAL CANNABIZ WOR
Page 25 and 26: WHAT TO EXPECT MEDICAL CANNABIZ WOR
Page 27 and 28: FEATURE ASIA - estimated medical ca
Page 29 and 30: COVER STORY CANNABIZ .1 29 ...
Page 31 and 32: COVER STORY “Why Malta? It’s ve
Page 33 and 34: COVER STORY Just amazing people. An
Page 35 and 36: FEATURE The art of medicine consist
Page 37 and 38: FEATURE LAURA TABONE, EVENTS DIRECT
Page 39 and 40: CATAGORY Q&A “This year has been
Page 41: Q&A it a detriment? Lawyers believe
Page 44 and 45: FEATURE CANNABIZ .1 44
Page 46 and 47: MEDICAL CANNABIS ADVISORY REGULATOR
Page 49 and 50: CATAGORY GALLERY CANNABIZ .1 49
Page 51 and 52: GALLERY CANNABIZ .1 51
Page 53 and 54: GALLERY CANNABIZ .1 53
Page 55 and 56: FEATURE At Green Goblin, we have pl
Page 57 and 58: Q&A WHAT ARE THE BIGGEST CHALLENGES
Page 59: Q&A We also focus on design & build
Page 62 and 63: FEATURE “I think this is the big
Page 64 and 65: FEATURE THE MEDICAL CANNABIS REVOLU
Page 66 and 67: CATAGORY OPINION POT LUCK AS MORE R
Page 70 and 71: FEATURE CROSSING THE FRONTIER CANNA
Page 72 and 73:
FEATURE “Given the use of CBD ing
Page 74 and 75:
WHO’S WHO DR. AARON BENSIMON - CE
Page 76 and 77:
THE UK’S LARGEST HEMP & CBD EXPO
Page 78 and 79:
WHO’S WHO DIMA CHERNOBILSKY - CEO
Page 80 and 81:
WHO’S WHO DAMON BOOTH - FOUNDER w
Page 82:
WHO’S WHO TRACY RYAN - CEO www.ca
show all

Cannabiz Issue 1

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?